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Introduction
Exploration of the origins and evolution of tuberculosis necessarily relies on the clear unambiguous identification of ancient well-characterised archaeological specimens. It would be advantageous to identify an extended population of infected individuals but, given the likely scarcity of the oldest examples, investigation of single landmark cases may well be a productive option. If studies of isolated cases are well-conducted and published in established peer-reviewed journals, the results achieved must be properly respected. In this report, the incontrovertible evidence for tuberculosis in the oldest human 1 and animal 2 cases, described to date, will be reviewed and some new data included.
The widest possible combination of complementary methods should be used to diagnose ancient mycobacterial disease. For skeletal material, considerable expertise has been developed in recognising characteristic bone changes linked to tuberculosis infection. 3, 4 The precise diagnosis of tuberculosis disease requires recognition of decisive biomarkers 5 for the causative agent Mycobacterium tuberculosis. The amplification of key DNA sequences has been systematically developed into widely-applied protocols, during the past two decades During the past twenty years, DNA fragment analysis has been extensively utilised. 5 Major advances in determining full genomic data have been recently provided by the application of so-called "Next Generation Sequencing" 6 and the more direct "Metagenomic" approach. 7 The predominant feature of the tubercle bacillus is the presence of high proportions of long-chain lipids, easily distinguishable from any mammalian lipids. In a pioneering study, the 70 to 90 carbon mycolic acids (MAs) ( Figure 1A) were clearly identified in a mediaeval bone from Addingham, UK, complementing DNA amplification and skeletal indications. 8 The biomarker range has been extended to include multi-methyl-branched mycocerosic and mycolipenic acids ( Figure 1B ). 2, 9 MAs were originally analysed by fluorescence High Performance Liquid Chromatography (HPLC) of slightly unstable methylanthryl esters, 8 pre-pottery settlement at Atlit-Yam, Israel (~9,000 ka) 1 and an extinct Bison antiquus metacarpal from Natural Trap Cave, Wyoming (~17,000 ka). 2 However, these clear diagnostic data are occasionally overlooked 4 , so in this communication the data for these two landmark cases are presented together and reinforced by some new lipid results.
Landmark studies

2.1
Nine thousand year old woman and child, Atlit-Yam, Israel
Archaeological investigations off the coast at Atlit-Yam revealed a submerged coastal pre-pottery, post-domestication Neolithic settlement, which included skeletal material from a woman and infant with lesions suggestive of tuberculosis. 1, 10 In particular, the inner aspect of the infant cranial bones had serpentine engravings (serpens endocrania symmetrica, SES), considered to be diagnostic for intra-thoracic inflammation associated with tuberculosis. 1, 11 The tubular bones from the infant, and to a lesser extent from the adult, also demonstrated lesions identified as hypertrophic osteoarthropathy (HOA), highly suggestive of tuberculosis. 1, 12 Encouraging results were also achieved for the PCR amplification and sequencing of the M. tuberculosis DNA insertion elements IS6110 and IS1081, 1 but additional confirmation was desirable.
Carefully crafted robust lipid biomarker studies were found to be ideal complements to the above compelling evidence for TB in the Atlit-Yam skeletons. 1 The chosen bone samples were degraded by a proven alkaline hydrolysis, 1,2,8 designed to release the maximum amount of mycobacterial lipid biomarkers. Quantitative conversion of the acidic fatty components to pentafluorobenzyl (PFB) esters gave lipid biomarkers the ability to be separated reproducibly on silica gel cartridges into fractions containing PFB mycolipenate/mycocerosates, PFB mycolates and free phthiocerols ( Figure 1 ). The latter two lipid classes were converted to stable pyrenebutyric acid (PBA) esters, ideal for sensitive fluorescence HPLC, with the PFB mycocerosate/mycolipenates being amenable to NI-CI GC-MS. The assembled lipid biomarker profiles for the Atlit-Yam specimens are shown in Figure 2 .
A simple logical sequence is followed for the HPLC characterisation of mycolic acid derivatives. The initial "reverse phase" HPLC ( Figure 2A ) serves to isolate and observe any C 70 -C 90 mycolates free from any smaller mammalian lipids. A "tight envelope" of total mycolate peaks, as recorded in Figure 2A To support the positive mycolate results, the mycocerosate/mycolipenate ( Figure 1B Figure 1B) were recorded for specimens taken both at the lesion (Bison 1) and a remote site (Bison 2) ( Figure 3F-H) . The initial reverse phase HPLC profiles of the PBA derivatives of the phthiocerol family fraction ( Figure 3I ) were not as clean as those for the Atlit-Yam skeletons ( Figure 2J ). Normal phase analysis ( Figure 3J ) of the collected material from the reverse phase separation ( Figure 3I ) confirmed the presence of members of the phthiocerol family, as published previously. 2 In addition, to the phthiocerols, however, the full normal phase profiles of the PBA derivatives showed the presence of ill-defined more-polar components, labelled X, Y and Z in Figure 3J . The presence of these unknown components was not reported in the initial study, 2 as their identity could not be readily understood. One possible explanation is that components X -Z are derived from glycosyl phenolphthiocerols, the deacylated so-called "phenolic" glycolipids (PGLs). To investigate this hypothesis, the PGL from M. bovis BCG was processed through the hydrolysis and extraction protocols and it was found that the resulting PBA derivatives chromatographed in a similar fashion to the components X, Y and Z (data not shown). Unfortunately, none of the X -Z material remained from the bison samples, so it was not possible to make a precise direct comparison. The key conclusion, however, is that the material from Atlit-Yam does not
show the presence of these potential biomarkers, possibly derived from PGLs ( Figure 2J ).
Many modern isolates of M. tuberculosis do not produce PGLs, but they are found in M.
bovis, M. africanum, certain M. tuberculosis Beijing strains and smooth morphology isolates labelled "Mycobacterium canettii". A recent detailed study 13 has confirmed that "M. canettii" strains are likely ancient progenitors of modern tuberculosis. The aDNA studies 12 ruled out M. bovis, but indicated a similarity with M. africanum. Further studies will be needed to determine the precise strain of tubercle bacillus infecting the Natural Trap Cave bison.
Conclusions
Sound evidence has been assembled, therefore, for the clear diagnosis of tuberculosis in Genomic studies suggest a rapid expansion of modern biotypes of the tubercle bacillus following an apparent evolutionary bottleneck at the end of the Pleistocene. 13 Figure 3 
